Long-Term Outcome of Intact Abdominal Aortic Aneurysm After Endovascular or Open Repair

医学 围手术期 危险系数 腹主动脉瘤 腔内修复术 倾向得分匹配 外科 优势比 置信区间 回顾性队列研究 动脉瘤 队列 主动脉瘤 存活率 内科学
作者
Jasmin Epple,Yuliya Svidlova,Thomas Schmitz‐Rixen,Dittmar Böckler,Neelam Lingwal,Reinhart T. Grundmann
出处
期刊:Vascular and Endovascular Surgery [SAGE Publishing]
卷期号:57 (8): 829-837 被引量:3
标识
DOI:10.1177/15385744231178130
摘要

Endovascular aortic aneurysm repair (EVAR) has been established as a standard treatment option for intact abdominal aortic aneurysm (iAAA) and gained importance due to a lower perioperative mortality than open repair (OAR). However, whether this survival advantage can be maintained or if OAR is beneficial in terms of long-term complications and reinterventions remains questionable.In this retrospective cohort study data from patients undergoing elective EVAR or OAR for iAAAs in the years 2010-2016 was analyzed. The patients were followed through 2018.In the propensity score matched cohorts the perioperative and long-term outcomes of the patients were assessed. We identified 20 683 patients undergoing elective iAAA repair (76.4% EVAR). The propensity matched cohorts included 4886 pairs of patients.The perioperative mortality was 1.9% for EVAR and 5.9% for OAR (P = <.001). The perioperative mortality was mainly influenced by patients age (Odds-Ratio (OR):1.073, confidence interval (CI):1.058-1.088, P ≤ .001) and OAR (OR:3.242, CI:2.552-4.119, P ≤ .001). The early survival benefit after endovascular repair persisted for approximately 3 years (estimated survival EVAR 82.3%, OAR 80.9%, P = .021). After that time the estimated survival curves were similar. After 9 years the estimated survival was 51.2% after EVAR as compared to 52.8% after OAR (P = .102). The operation method didn't influence long-term survival significantly (Hazard-Ratio (HR): 1.046, CI: .975-1.122, P = .211). The vascular reintervention rate was 17.4% in the EVAR cohort and 7.1% in the OAR cohort (P ≤ .001).EVAR has a significantly lower perioperative mortality than OAR, a survival benefit that lasts up to 3 years after intervention. Thereafter, no significant difference in survival was observed between EVAR and OAR. The decision between EVAR or OAR may depend on patient preference, surgeons' experience, and the institutions' ability to handle complications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顾矜应助wang采纳,获得10
1秒前
2秒前
CSH应助yinbohong采纳,获得10
2秒前
西瓜炒蛋发布了新的文献求助10
2秒前
灯光系统完成签到,获得积分10
4秒前
科研mrxu完成签到,获得积分10
4秒前
5秒前
cdj发布了新的文献求助10
5秒前
在水一方应助A2150530290采纳,获得10
7秒前
诚心金渐基完成签到 ,获得积分10
7秒前
8秒前
酷波er应助阿臭der采纳,获得10
9秒前
10秒前
10秒前
jzy发布了新的文献求助10
12秒前
12秒前
WERTUYU发布了新的文献求助10
14秒前
呵呵发布了新的文献求助10
15秒前
15秒前
YM发布了新的文献求助10
15秒前
thorndikescat完成签到,获得积分10
16秒前
火星上的天宇完成签到,获得积分10
16秒前
刘露完成签到,获得积分10
17秒前
iii完成签到,获得积分10
18秒前
森sen发布了新的文献求助30
19秒前
mbf发布了新的文献求助10
20秒前
李珂完成签到,获得积分10
20秒前
22秒前
23秒前
Avalonx应助月亮上的猫采纳,获得10
25秒前
白门小强发布了新的文献求助10
26秒前
jzy完成签到,获得积分20
27秒前
27秒前
tangz发布了新的文献求助10
27秒前
29秒前
29秒前
30秒前
30秒前
32秒前
NexusExplorer应助茶米采纳,获得10
33秒前
高分求助中
Markov Chain Monte Carlo 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Common Foundations of American and East Asian Modernisation: From Alexander Hamilton to Junichero Koizumi 1000
Weaponeering: An Introduction Fourth Edition, Volume 1 1000
Advanced Weaponeering Fourth Edition, Volume 2 1000
Evidence Summary. Injection (subcutaneous):op- timal administration 1000
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7499148
求助须知:如何正确求助?哪些是违规求助? 9089906
关于积分的说明 19390812
捐赠科研通 7109497
什么是DOI,文献DOI怎么找? 3250567
关于科研通互助平台的介绍 2419936
邀请新用户注册赠送积分活动 2236435